Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxylamine succinate tablets for short-term insomnia (Phase III)
CTR20202295Phase 3Completed
- Sponsor
- Suzhou Fourth Pharmaceutical Factory
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxylamine in Insomnia, sponsored by Suzhou Fourth Pharmaceutical Factory. Started Dec 2020; status: completed.
02
Drugs
doxylamine
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20202295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202295.